NIIMBL is excited to launch a Request for Applications (RFA) for 2027 NIIMBL eXperience regional lead organizations. This opportunity invites applications from NIIMBL academic and nonprofit members to design and host a weeklong summer program that introduces first- and second-year college students to the biopharmaceutical manufacturing industry. Selected regional leads will shape an engaging experience featuring hands-on training, mentoring, tours, and industry engagement. This is a unique chance to inspire emerging talent, showcase your capabilities, and help build the future biopharmaceutical workforce.
The application deadline is July 20, 2026 (5 pm ET).
NIIMBL has launched a new Submission Hub. Applicants are required to register before submitting an application; to do so, please contact [email protected] to request user access. We recommend registering several days or weeks in advance of the submission deadline to avoid delays.
The NIIMBL eXperience is an exclusive in-person, all expenses paid immersion program that gives students unparelleled access to the biopharmaceutical industry. Over the course of a week, participants dive into hands-on activities, explore real manufacturing environments, and connect directly with industry professionals who are shaping the future of biopharma.
Program goals include:
Join us for an NIIMBL eXperience Listening Session on Thursday, May 21, 2026, from 12 -1 pm ET. The session will offer a chance for you to ask questions about the RFA.
No registration is required. The session will be recorded.
| April 30, 2026 | RFA Release |
| May 21, 2026 (noon ET) | NIIMBL eXperience RFA Listening Session |
| July 20, 2026 (5:00 pm ET) | Application Deadline |
| ~ August 1, 2026 | Anticipated Award Decisions and Notification to Teams |
| October 1, 2026 | Project Start Date |
If you have questions regarding the NIIMBL eXperience RFA, contact us at [email protected].
We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.
